Proper diabetes education at a young age can reduce amount of common errors… The primary clinical objective to be achieved with insulin therapy initiation is the elimination of ketosis and hyperglycemic events with prevention of chronic problems. Insulin therapy is the primary management of type 1 diabetes, which should be …
Read More »New Study Shows Metformin Resides in Gut, Not Circulation
Even though metformin delayed release resides in gut, it still maintains glucose-lowering effect… Metformin has been known to be the first line treatment for type 2 diabetes if the side effects are tolerable. According to new study published by Diabetes Care, metformin delayed release (metformin DR) primary effect is in …
Read More »T2D Better Diagnosed Using One-Hour Post-Load Hyperglycemia
Study shows that impaired fasting glucose is less accurate diagnostic tool… Patients with normal glucose tolerance (NGT) and 1-hour post-load plasma glucose level of ≥155 mg/dl have a higher cardio-metabolic risk profile compared to patients with NGT and impaired glucose tolerance (IGT), according to The Journal of Clinical Endocrinology …
Read More »Outcome of Degludec and Glargine on Fasting Plasma Glucose in T1D Patients
Insulin has different impact on fasting plasma glucose and day-to-day changes… The duration of action for degludec is approximately 42 hours and is much longer than the duration of action of glargine. Due to degludec pharmacokinetics, it leads to a slower absorption rate from the injection site to the blood …
Read More »Old Shoes Best Fit When New Shoes Bring New Problems
Two weeks ago, a patient came in to the pharmacy complaining that his feet were burning and sore, and he was developing blisters on the top of his left foot. The patient had diabetes for about 13 years and had recently been running an A1c of 7.9. He was also …
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 3 of 6
George Bakris, MD, continues his discussion with Diabetes in Control Publisher Steve Freed. This week, the focus is why certain ethnic groups are more suscepticle to developing kidney disease, with or without diabetes. With the detection of the gene leading to kidney disease, more aggressive preventative treatment can be implemented …
Read More »TeamNovoNordisk Rider interviews
KEVIN DE MESMAEKER 1. What does your morning include before a race? What do you eat for breakfast all the way until race start? I wake up and immediately check my blood sugar. Then I take my medication and usually go to breakfast. At breakfast, I like to eat oatmeal …
Read More »Consumption of Saturated Fats Shows No Significant Risk of Mortality
Inconclusive evidence continues to ping-pong back and forth about whether or not saturated fats have health risks associated with them… A recent synthesis of observational evidence was published in BMJ after scouring through previously published literature in healthy adults. As a systematic review, this study sought to evaluate associations between …
Read More »Increased Glucagon Levels Paradoxically Associated with Liraglutide
A recent study lists liraglutide as potentially having an early, unanticipated effect on glucagon in type 2 diabetes patients… In a recent randomized controlled trial, authors evaluated the use of liraglutide in 51 patients with type 2 diabetes for an average of 2.6 years. Patients were given either liraglutide or …
Read More »The Relationship Between Renal and Retinal Disorder in Type 2 Diabetes
Researchers study retinopathy as possible indicator of nephropathy… The number of diabetes mellitus cases is on the rise while the incidence of end-stage kidney disease from diabetes has decreased over the years. However, diabetes remains the main cause of end-stage kidney disease in the United States and other countries. There …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.